Hangzhou Minsheng Healthcare Co., Ltd. (SHE:301507)
15.22
-0.20 (-1.30%)
Feb 2, 2026, 4:00 PM EST
SHE:301507 Revenue
Hangzhou Minsheng Healthcare had revenue of 160.17M CNY in the quarter ending September 30, 2025, with 30.84% growth. This brings the company's revenue in the last twelve months to 744.06M, up 20.85% year-over-year. In the year 2024, Hangzhou Minsheng Healthcare had annual revenue of 641.25M with 10.23% growth.
Revenue (ttm)
744.06M
Revenue Growth
+20.85%
P/S Ratio
7.29
Revenue / Employee
1.45M
Employees
514
Market Cap
5.43B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 641.25M | 59.52M | 10.23% |
| Dec 31, 2023 | 581.73M | 34.61M | 6.33% |
| Jan 1, 2023 | 547.12M | 57.54M | 11.75% |
| Dec 31, 2021 | 489.58M | 50.15M | 11.41% |
| Dec 31, 2020 | 439.43M | 88.94M | 25.38% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nanjing Pharmaceutical Group Company | 53.89B |
| Zhejiang Int'l Group | 33.54B |
| Shanghai Shenqi Pharmaceutical Investment Management | 1.88B |
| GuangYuYuan Chinese Herbal Medicine | 1.39B |
| Shanghai InnoStar Bio-tech | 829.92M |
| Chongqing Lummy Pharmaceutical | 771.02M |
| Hangzhou Bio-Sincerity Pharma-Tech | 590.33M |
| Zhejiang Haisen Pharmaceutical | 510.33M |